
Weight Loss &
Growth Hormone
Metabolic & body composition support
GLP-1 Treatment
Certain approved medicines help eligible patients manage weight alongside nutrition and activity. Your provider will review options and risks.
AOD-9604
Investigational peptide. Weight-loss benefits are not established.
CJC / Ipamorelin
Investigational combination. Benefits and long-term safety remain uncertain.
Tesamorelin / Ipamorelin
This combination is not FDA-approved. Tesamorelin’s approved use is specific to excess abdominal fat in adults with HIV-associated lipodystrophy.
Sermorelin
A growth hormone-releasing hormone analogue. Historical pediatric approval does not establish anti-aging benefits in adults.


